The calcium channel blocker lacidipine slows the progression of carotid atherosclerosis

Affiliations

Comment

Prediman K Shah. Rev Cardiovasc Med. 2003 Summer.

. 2003 Summer;4(3):191-2.

¹ Division of Cardiology, Cedars-Sinai Medical Center and The David Geffen School of Medicine at UCLA, Los Angeles, California, USA.

No abstract available

Comment on

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial.
Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palù C, Hansson L, Magnani B, Rahn KH, Reid JL, Rodicio J, Safar M, Eckes L, Rizzini P; European Lacidipine Study on Atherosclerosis investigators. Zanchetti A, et al. Circulation. 2002 Nov 5;106(19):2422-7. doi: 10.1161/01.cir.0000039288.86470.dd. Circulation. 2002. PMID: 12417537 Clinical Trial.